Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

The company will keep the systems on the market but is asking providers to check devices for visible cracks and return ...

This significant investment marks a pivotal moment for REEV, fueling its mission to revolutionize mobility and restore ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth ...

The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of ...

Brent Shafer, Baxter’s lead independent director, will serve as interim CEO. The company also promoted Heather Knight to ...

The investment in the facility in Cork, Ireland, is part of GE Healthcare’s push to close the gap between supply and demand. In 2022, the company committed $80 million to boost production of contrast ...